Literature DB >> 12193434

Respiratory depression in the acute management of seizures.

W A Stewart1, R Harrison, J M Dooley.   

Abstract

The incidence of respiratory depression following treatment of prolonged seizures with benzodiazepines is variable in the literature. We retrospectively reviewed the charts of children treated for prolonged seizure over a one year period. Of the 56 seizures treated, 30 received lorazepam, 19 diazepam, and seven both drugs. Twenty two episodes (39%) of prolonged seizure were treated with multiple doses of benzodiazepines. In eight events (14%), there was documented respiratory depression following the administration of one or more doses of benzodiazepine; in six of these, multiple doses were given. The doses used were often at the low end or less than the recommended dose for treatment of status epilepticus. These data support suggestions that multiple doses of benzodiazepines increase the risk of respiratory depression.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12193434      PMCID: PMC1719214          DOI: 10.1136/adc.87.3.225

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  8 in total

1.  Inappropriate emergency management of status epilepticus in children contributes to need for intensive care.

Authors:  R F M Chin; L Verhulst; B G R Neville; M J Peters; R C Scott
Journal:  J Neurol Neurosurg Psychiatry       Date:  2004-11       Impact factor: 10.154

2.  Lorazepam-induced prolonged apnea after ECT-induced prolonged seizure.

Authors:  Dattatreya Dhavale; Vidyadhar Watve; Chittaranjan Andrade
Journal:  Indian J Psychiatry       Date:  2011-01       Impact factor: 1.759

Review 3.  Optimal Management of Status Epilepticus in Children in the Emergency Setting: A Review of Recent Advances.

Authors:  Shrouk Messahel; Louise Bracken; Richard Appleton
Journal:  Open Access Emerg Med       Date:  2022-09-17

4.  Patterns of benzodiazepine underdosing in the Established Status Epilepticus Treatment Trial.

Authors:  Abhishek G Sathe; Ellen Underwood; Lisa D Coles; Jordan J Elm; Robert Silbergleit; James M Chamberlain; Jaideep Kapur; Hannah R Cock; Nathan B Fountain; Shlomo Shinnar; Daniel H Lowenstein; Eric S Rosenthal; Robin A Conwit; Thomas P Bleck; James C Cloyd
Journal:  Epilepsia       Date:  2021-02-10       Impact factor: 5.864

5.  Adverse drug reactions causing admission to a paediatric hospital.

Authors:  Ruairi M Gallagher; Jennifer R Mason; Kim A Bird; Jamie J Kirkham; Matthew Peak; Paula R Williamson; Anthony J Nunn; Mark A Turner; Munir Pirmohamed; Rosalind L Smyth
Journal:  PLoS One       Date:  2012-12-04       Impact factor: 3.240

6.  Necessity of lumbar puncture in patients presenting with new onset complex febrile seizures.

Authors:  Erin M Fletcher; Ghazala Sharieff
Journal:  West J Emerg Med       Date:  2013-05

7.  Treatment of community-onset, childhood convulsive status epilepticus: a prospective, population-based study.

Authors:  Richard F M Chin; Brian G R Neville; Catherine Peckham; Angie Wade; Helen Bedford; Rod C Scott
Journal:  Lancet Neurol       Date:  2008-07-02       Impact factor: 44.182

8.  Consistent safety and tolerability of Valtoco® (diazepam nasal spray) in relationship to usage frequency in patients with seizure clusters: Interim results from a phase 3, long-term, open-label, repeat-dose safety study.

Authors:  Ian Miller; James W Wheless; Robert E Hogan; Dennis Dlugos; Victor Biton; Gregory D Cascino; Michael R Sperling; Kore Liow; Blanca Vazquez; Eric B Segal; Daniel Tarquinio; Weldon Mauney; Jay Desai; Adrian L Rabinowicz; Enrique Carrazana
Journal:  Epilepsia Open       Date:  2021-05-13
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.